Pseudomonas Aeruginosa Treatment

Pseudomonas Aeruginosa Pneumonia Pipeline Review, H2 2020 - Therapeutic Assessment of 4 Companies & 7 Drug Profiles - ResearchAndMarkets.com    Business Wire

Mutation-induced remodeling of the BfmRS two-component system in Pseudomonas aeruginosa clinical isolates    Science

Merck to Present New Data from its Extensive Infectious Diseases and Vaccines Pipeline and Portfolio During IDWeek 2020    The Baytown Sun

EPA’s Draft Residual Efficacy Protocols for “Long-Lasting” Efficacy for Antiviral Products    JD Supra

Intravesical Phage Therapy May Treat UTI in Men Undergoing TURP    Renal and Urology News

Phase 3 trials show positive results for cefiderocol, but questions remain    CIDRAP

Form 6-K RedHill Biopharma Ltd. For: Oct 07    StreetInsider.com

Shionogi Announces FDA Approval of FETROJA® (cefiderocol) for the Treatment of Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia    Odessa American

Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS    StreetInsider.com

Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumon    StreetInsider.com

Ecolab Synergex™ Sanitizer & Disinfectant First to Receive U.S. EPA Biofilm Claim    Business Wire

Anti-anaerobic therapy over-prescribed for patients with aspiration community-acquired pneumonia    2 Minute Medicine

Could Drug-Resistant Bacteria Cause The Next Pandemic?    Forbes

Coordinating a neutrophil swarm    Science

RedHill Biopharma's Phase 2/3 COVID-19 Study Approved in Mexico    GlobeNewswire

Pseudomonas Aeruginosa Infection Treatment Market Outlook 2026: Top Companies, Trends, Growth Factors Details by Regions, by Types and by Applications    3rd Watch News

Bronchiectasis Study Links Cardiovascular Disease to Exacerbation Risk    Bronchiectasis News Today

FDA approves Merck's Recarbrio for treating ventilator- and hospital-associated pneumonia    BioWorld Online

Sulfonamide Market Global Opportunity Analysis and Forecast 2019-2029    3rd Watch News

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options    MyChesCo